Christopher Holland

Biographical Sketch

Mr. Holland is a Biostatistics Director at Amgen. He has over 20 years of biostatistical experience across multiple environments including contract research organizations, pharmaceutical and biotechnology companies, and the US Food and Drug Administration where he worked as a safety statistician and a statistical reviewer for oncology products. He currently serves as the Global Statistical Lead for a breakthrough therapy that was approved for acute lymphoblastic leukemia in 2014. In addition to his varied biostatistical interests, Chris has extensive experience developing CDISC data standards and is the co-author of the book Implementing CDISC Using SAS: An End-to-End Guide. He is a professionally accredited statistician by the American Statistical Association, possesses an MS degree in Statistics from the University of Virginia, a BS in Statistics from Virginia Tech, and a graduate certificate in Computational Sciences from George Mason University.

Instant Short Conference

Mr. Holland has contributed to the following Instant Short Conference:


Browse the catalog of Instant Conferences and Instant Short Courses.

© 2008-2020 Supremum Group. All Rights Reserved.
Supremum Group | Terms of Use | Privacy Policy | Contact